Skip to main content

Table 2 Antithrombotic drug regimen at discharge

From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study

Medication

Median duration (months)

 

CHA2DS2-VASc = 1

CHA2DS2-VASc≥2

HASBLED≤2

HASBLED ≥3

P-value

Aspirin

2.3 ± 0.7

3.2 ± 1.1

3.8 ± 0.9

3.3 ± 0.9

>0.05

Clopidogrel

11.2 ± 2.8

12.9 ± 1.4

12.6 ± 2.5

10.3 ± 1.6

>0.05

Warfarin

10.5 ± 2.8

12.4 ± 1.3

11.8 ± 2.1

10.8 ± 2.7

>0.05

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us